1 / 4

Renal damage occurs in 1 out of 4 hypertensives

Renal damage occurs in 1 out of 4 hypertensives. Adapted from Leoncini et al. J Hypertens . 2008;26:427-432. Optimal protection should reduce the risk of death. Adapted from Dzau et al. Circulation . 2006;114;2850-2870 . .

thuraya
Télécharger la présentation

Renal damage occurs in 1 out of 4 hypertensives

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Renal damage occurs in 1 out of 4 hypertensives Adapted from Leoncini et al. J Hypertens. 2008;26:427-432.

  2. Optimal protection shouldreducethe risk of death Adapted from Dzau et al. Circulation. 2006;114;2850-2870.

  3. ADVANCE: renal protection that translates into mortality reduction * Versus patients, 73% of whom were receiving an ACE inhibitor or a sartan. ** Development of macroalbuminuria, doubling of serum creatinine to a level of at least 2.26 mg/dL (200 mol/L), need for renal replacement therapy or death due to renal disease. *** All-cause mortality. 1. De Galan et al. J Am Soc Nephrol. 2009;20:883-892. 2. Lambers Heerspink et al; ADVANCE Collaborative Group. Eur Heart J. 2010;31:2888-2896. 3. Patel et al; ADVANCE Collaborative Group. Lancet. 2007;370:829-840.

  4. Kidney protection translating into mortality reduction More extensive assessment is available in García-Donaire et al. Blood Press. 2011;20:322–334. *renal events, **urinary albumin/creatinine ratio; †urinary albumin excretion rate, ‡doubling serum creatinine. RRR = relative risk reduction; NS = not significant. Results should be interpreted line by line, in comparison with a control group specific to the trial.

More Related